Clinical Trial Details
| Trial ID: | L0249 |
| Source ID: | NCT00668070 |
| Associated Drug: | ASP9831 |
| Title: | A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 |
| Acronym: | ASTER |
| Status: | Completed |
| Study Results: | No Results Available |
| Results: | -- |
| Conditions: | Non-Alcoholic Steatohepatitis |
| Interventions: | Drug: ASP9831|Drug: Placebo |
| Outcome Measures: | ALT |
| Sponsor/Collaborators: | Astellas Pharma Inc |
| Gender: | All |
| Age: | 18 Years and older ?? (Adult, Older Adult) |
| Phases: | Phase 2 |
| Enrollment: | 114 |
| Study Type: | Interventional |
| Study Designs: | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment |
| Start Date: | April 2008 |
| Completion Date: | October 2010 |
| Results First Posted: | -- |
| Last Update Posted: | March 21, 2013 |
| Locations: | Antwerp, Belgium|Brussels, Belgium|Gent, Belgium|La Louviere, Belgium|Leuven, Belgium|Brno-Bohunice, Czech Republic|Prague, Czech Republic|Praha, Czech Republic|Amiens Cedex 1, France|Angers cedex 9, France|Montpellier cedex 5, France|Paris Cedex 13, France|Paris, France|Pessac, France|Berlin, Germany|Essen, Germany|Frankfurt am Main, Germany|Mainz, Germany|Regensburg, Germany|Bucharest, Romania|Bucharest, Romania|Iasi, Romania|Timisoara, Romania|Basel, Switzerland|Bern, Switzerland|Zurich, Switzerland|Birmingham, United Kingdom|London, United Kingdom|Newcastle upon Tyne, United Kingdom|Nottingham, United Kingdom |
| URL: | https://ClinicalTrials.gov/show/NCT00668070 |
